Your browser doesn't support javascript.
loading
Transfusion-transmitted HBV infection with isolated anti-HBs-positive blood.
Satake, Masahiro; Yamagishi, Naoji; Tanaka, Ami; Goto, Naoko; Sakamoto, Tomohiko; Yanagino, Yusuke; Furuta, Rika A; Matsubayashi, Keiji.
Afiliação
  • Satake M; Central Blood Institute, Japanese Red Cross, Tokyo, Japan.
  • Yamagishi N; Central Blood Institute, Japanese Red Cross, Tokyo, Japan.
  • Tanaka A; Central Blood Institute, Japanese Red Cross, Tokyo, Japan.
  • Goto N; Blood Service Headquarters, Japanese Red Cross, Tokyo, Japan.
  • Sakamoto T; Department of Cardiovascular Surgery, Sakurabashi-Watanabe Hospital, Osaka, Japan.
  • Yanagino Y; Department of Cardiovascular Surgery, Sakurabashi-Watanabe Hospital, Osaka, Japan.
  • Furuta RA; Central Blood Institute, Japanese Red Cross, Tokyo, Japan.
  • Matsubayashi K; Central Blood Institute, Japanese Red Cross, Tokyo, Japan.
Transfusion ; 63(6): 1250-1254, 2023 06.
Article em En | MEDLINE | ID: mdl-37129363
ABSTRACT

BACKGROUND:

Hepatitis B virus (HBV)-positive individuals with isolated anti-HBs are found among HBV vaccine recipients and healthy blood donors with no vaccination history. HBV infectivity from blood transfusions derived from such individuals remains unclear. CASE PRESENTATION A male patient who received transfusion with blood negative for individual donation-NAT, HBsAg and anti-HBc but weakly positive for anti-HBs developed typical transfusion-transmitted (TT)-HBV with anti-HBc response. The responsible blood donor was a frequent repeat donor showing a marked increase in anti-HBs titer without anti-HBc response 84 days after index donation. Test results for his past donations showed transient viremia with very low viral load and fluctuating low-level anti-HBs. The HBV vaccination history of this donor was unknown.

DISCUSSION:

Anti-HBs and anti-HBc kinetics of the donor suggest a second antibody response to new HBV challenge, representing a vaccine breakthrough case. On the other hand, transient low-level viremia and fluctuating anti-HBs in the test results of past donations suggested chronic occult HBV infection with isolated anti-HBs.

CONCLUSION:

Whatever the basic infection state, blood donors with isolated weak anti-HBs may include a small population with a risk of causing TT-HBV. Identifying individuals harboring such TT-HBV risk among individuals positive only for anti-HBs is difficult under current screening strategies. Active surveillance for the occurrence of TT-HBV with blood positive only for anti-HBs is necessary.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Hepatite B Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Hepatite B Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article